Literature DB >> 25406285

Benzalkonium chloride induces subconjunctival fibrosis through the COX-2-modulated activation of a TGF-β1/Smad3 signaling pathway.

Caihong Huang1, He Wang1, Juxin Pan1, Dan Zhou1, Wensheng Chen2, Wei Li2, Yongxiong Chen1, Zuguo Liu2.   

Abstract

PURPOSE: The purpose is to investigate the mechanism of subconjunctival fibrosis caused by benzalkonium chloride (BAC), which is the most common preservative in ophthalmic preparations.
METHODS: The left eyes of male Sprague-Dawley rats were topically treated with 0.01% BAC or PBS twice daily for 1 month. Primary conjunctival fibroblasts (CFs) were exposed for 24 hours to 0.00005% BAC, 0.000075% BAC, 0.000075% BAC + LY2157299 (a selective transforming growth factor β receptor type I inhibitor); 0.000075% BAC + NS-398 (a selective cyclooxygenase-2 inhibitor) and PBS, respectively. The pathological changes of the bulbar conjunctival tissue of rats were examined using hematoxylin-eosin (HE), Van Gieson's (vG), periodic acid-Schiff (PAS) stains, or immunohistochemisty (IHC). The expression of the extracellular matrix (ECM), the transforming growth factor β (TGF-β) signaling pathway-related molecules, and cyclooxygenase-2 (COX-2) in bulbar conjunctival tissues and CFs were detected using Western blot (WB) and quantitative real-time RT-PCR (qRT-PCR).
RESULTS: Rats treated with 0.01% BAC exhibited a slight increase of the fibroblast density and a more compact collagen deposition in the bulbar subepithelial connective tissues in comparison with rats treated with PBS. Western blot and qRT-PCR analyses showed that the expression of ECM, TGF-β signaling pathway-related molecules, and COX-2 were markedly increased in the bulbar conjunctival tissues of rats exposed to 0.01% BAC and in CFs exposed to 0.00005% and 0.000075% BAC. In conjunctival fibroblasts, BAC-induced ECM expression was clearly decreased by LY2157299, while the BAC-induced activation of the TGF-β1/Smad3 signaling pathway was greatly attenuated by NS-398.
CONCLUSIONS: Subconjunctival fibrosis BAC-induced is a consequence of excessive ECM production of CFs through the COX-2-modulated activation of a TGF-β1/Smad3 signaling pathway. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  benzalkonium chloride; cyclooxygenase-2; extracellular matrix; subconjunctival fibrosis; transforming growth factor-β

Mesh:

Substances:

Year:  2014        PMID: 25406285     DOI: 10.1167/iovs.14-14504

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Ethylparaben induces subconjunctival fibrosis via the Wnt/β-catenin signaling pathway.

Authors:  Fengge Liu; Xiangfeng Kong; Hui Kong
Journal:  Exp Ther Med       Date:  2021-01-28       Impact factor: 2.447

2.  Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves' orbital fibroblasts.

Authors:  Chieh-Chih Tsai; Shi-Bei Wu; Hui-Chuan Kau; Yau-Huei Wei
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

3.  COX-2/sEH Dual Inhibitor PTUPB Attenuates Epithelial-Mesenchymal Transformation of Alveolar Epithelial Cells via Nrf2-Mediated Inhibition of TGF-β1/Smad Signaling.

Authors:  Chen-Yu Zhang; Xin-Xin Guan; Zhuo-Hui Song; Hui-Ling Jiang; Yu-Biao Liu; Ping Chen; Jia-Xi Duan; Yong Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-04-25       Impact factor: 7.310

Review 4.  A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications.

Authors:  Xiaoyu Zhou; Xinyue Zhang; Dengming Zhou; Yang Zhao; Xuanchu Duan
Journal:  Ophthalmol Ther       Date:  2022-08-09

Review 5.  The use of poly(styrene-block-isobutylene-block-styrene) as a microshunt to treat glaucoma.

Authors:  Leonard Pinchuk; Isabelle Riss; Juan F Batlle; Yasushi P Kato; John B Martin; Esdras Arrieta; Paul Palmberg; Richard K Parrish; Bruce A Weber; Yongmoon Kwon; Jean-Marie Parel
Journal:  Regen Biomater       Date:  2016-02-25

Review 6.  The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma.

Authors:  Leonard Pinchuk; Isabelle Riss; Juan F Batlle; Yasushi P Kato; John B Martin; Esdras Arrieta; Paul Palmberg; Richard K Parrish; Bruce A Weber; Yongmoon Kwon; Jean-Marie Parel
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2015-09-18       Impact factor: 3.368

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.